2023

Four new projects supported by our Foundation

In June 2023, our corporate Foundation and its Endowment Fund supported Audition Solidarité, Génération avant-garde, Fratries and Afuté

ORPHELIA Pharma will participate to the ANR 2023

Jeremy Bastid, Chief Development Officer at ORPHELIA Pharma will attend the Advances in Neuroblastoma Research (ANR) meeting to be held May 15-18, 2023 in Amsterdam, the Netherlands.

ORPHELIA Pharma will participate to the SIOPe 2023

We are pleased to announce that Jeremy Bastid, Chief Development Officer, and Hugues Bienaymé, General Manager and Chief Scientific Officer at ORPHELIA Pharma, will attend SIOP Europe 2023. We will be present at booth #10 located near the entrance doors to Auditorium 1.

ORPHELIA Pharma Selects Tanner Pharma to Initiate Named Patient Program for KIMOZO®

Jeremy BASTID, CEO of OREGA Biotech, will participate to the upcoming AACR annual meeting to be held on April 14-19 in Orlando, Florida

ORPHELIA Pharma announces completion of patient recruitment for the TEMOkids clinical trial

One new project supported by our Foundation

In February 2023, our corporate Foundation and its Endowment Fund supported Animal’Hom